Capital Performance Advisors’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-4
Closed -$728 1489
2024
Q3
$728 Buy
+4
New +$728 ﹤0.01% 2072